Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 18 of 38
Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma
NCT03120676
Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant
NCT03116997
Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors
NCT03114566
Imaging With a New Agent That Finds a Cancer Protein Called HER2
NCT03109977
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
NCT03056638
Adaptive Radiotherapy for Head and Neck Cancer
NCT03096808
Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies
NCT03082677
Risk Stratification Among Individuals Who Have Many Moles on Their Skin
NCT03080948
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
NCT03076164
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery
NCT03070340
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
NCT03070301
Investigation of the Effects of Electronic Cigarettes on Vascular Health
NCT03041493
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma
NCT03033303
Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT03030885
Study of Cognitive Behavioral Therapy for Insomnia (CBT-I) and Acupuncture for Insomnia and Related Distress Among Cancer Caregivers
NCT03012425
Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma
NCT03026517
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer
NCT03015129
Mobile Health Device Study for Myeloma Patients
NCT03006315
Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In Vivo
NCT03004053
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
NCT02954536
Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy
NCT02966730
Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients
NCT02924324
High Dose Carfilzomib for Newly Diagnosed Myeloma
NCT02937571
Trial of YUMI Uterine Manipulator
NCT02923544
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study
NCT02928549
Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers
NCT02928185
A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers
NCT02910726
Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet
NCT02902107
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
NCT02880293
Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community
NCT02914899
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900
A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing
NCT02895880
A Study to Assess Thymic Function Using PET/CT and MRI
NCT02909075
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
NCT02912767
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
NCT02836093
Sleep in Hospitalized Children at MSKCC
NCT02836041
The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative Analysis
NCT02836535
Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
NCT02833883
A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma
NCT02831686
Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas
NCT02849171
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers
NCT02803203
Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
NCT02833246
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
NCT02819843
Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients
NCT02730130
A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer
NCT02833233
Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention
NCT02747160
AASUR in High Risk Prostate Cancer
NCT02772588
Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection
NCT02770326
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
NCT02756247
TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
NCT02764333
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.